N-((3-(3-FLUORO-4-(2H-1,4-OXAZIN-4(3H)-YL)PHENYL)-2-OXOOXAZOLIDIN-5-YL)METHYL)ACETAMIDE, (S)-
UNII CT7B4Y7LWD
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((3-(3-fluoro-4-(2h-1,4-oxazin-4(3h)-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CT7B4Y7LWD.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1997296-64-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H18FN3O4 GUNAQMQLEYZYIT-ZDUSSCGKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((3-(3-fluoro-4-(2h-1,4-oxazin-4(3h)-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.